GRIM-19 ameliorates multiple sclerosis through reciprocal regulation of IFNγ/Th1 and IL-17A/Th17 cells in a mouse model of experimental autoimmune encephalomyelitis (20). The gene discussed is IL17A; the disease is multiple sclerosis.